Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
Can you apply?
This grant is for early-stage researchers and institutions working on translational drug discovery and assay development. Eligible applicants include research institutions, universities, and NIH-supported research centers. Projects must demonstrate innovative approaches to identifying and validating therapeutic agents or developing screening assays. Geographic scope includes U.S. institutions and their international collaborators. Funding supports high-risk, high-reward research at the early translational stage before large clinical trials.
Key dates
- Feb 25, 2026 Applications open
- Sep 30, 2026 Application deadline in 121 days
- Jul 1, 2027 Award announced
- Jul 1, 2027 Project start
This grant is for early-stage researchers and institutions working on translational drug discovery and assay development. Eligible applicants include research institutions, universities, and NIH-supported research centers. Projects must demonstrate innovative approaches to identifying and validating therapeutic agents or developing screening assays. Geographic scope includes U.S. institutions and their international collaborators. Funding supports high-risk, high-reward research at the early translational stage before large clinical trials.
Program description
The National Institute of Neurological Disorders and Stroke, National Institute of Aging, the NIH Helping to End Addiction Long Term (HEAL) initiative, and other participating NIH Institutes/Centers (ICs) seek to support applications to develop in vitro, ex vivo or in vivo assays and conduct screening efforts with the goal of identifying and characterizing potential therapeutic agents for disorders or diseases supported by participating ICs, or for non-opioid analgesic therapeutics with little or no addiction liability as a part of the NIH Helping to End Addiction Long Term (HEAL) initiative. Therapeutic agents include small molecules and biologics. Assays utilizing New Approach Methodologies (NAMs) may be used when appropriate.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- County Government
- Nonprofits
- Private University
- Public Authority
- Public K-12 School
- Public University
- Small Business (SBA-defined)
- Special District
- State Government
- Tribal Nation
- Tribal Organization
Details
This grant is for early-stage researchers and institutions working on translational drug discovery and assay development. Eligible applicants include research institutions, universities, and NIH-supported research centers. Projects must demonstrate innovative approaches to identifying and validating therapeutic agents or developing screening assays. Geographic scope includes U.S. institutions and their international collaborators. Funding supports high-risk, high-reward research at the early translational stage before large clinical trials.
How to apply
Application links
Key dates & requirements
Required documents
- R21 Application Form (SF-424 or equivalent)
- Project Narrative and Research Plan
- Biographical Sketches (NIH format)
- Budget and Budget Justification
- Institutional Support Letter
- Preliminary Data
Program contact
- 👤 NINDS_IGNITE@nih.gov
- 📧 NINDS_IGNITE@nih.gov
- 📞 Please contact via email
Funding track record
Recent awards under CFDA 93.853 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$82,511,281
-
$67,362,785
-
$62,646,087
-
$56,144,651
-
$45,268,737
-
$40,959,789
-
$35,655,349
-
$35,655,116
-
$35,335,145
-
$34,183,297
Top States by Funding
- MA 6 awards $186.5M
- CA 4 awards $129.9M
- OH 4 awards $112.5M
- FL 3 awards $100.3M
- MN 2 awards $99.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.853). How funding has trended year over year.
| 2024 | $2,362,835,459 | |
| 2025 | $2,345,500,401 |
FAQ
Who is eligible to apply?
Research institutions, universities, and research centers with NIH funding capacity. PIs must have appropriate research credentials and institutional support.
What types of projects are funded?
Early-stage assay development, therapeutic target identification, and drug screening methods. Projects should be innovative but not yet ready for large clinical investment.
What is the typical funding range?
IGNITE grants typically fund projects with modest budgets suitable for initial translational work. Check the current funding opportunity announcement for exact amounts.
How competitive is this grant?
IGNITE programs are moderately competitive. Strong preliminary data and clear innovation significantly improve competitiveness.
When is the deadline?
Application opening date is February 25, 2026. Check NIH Grants.gov for the specific submission deadline.
💡 Tips for applicants
- Emphasize innovation and novelty in your assay or therapeutic approach. Standard methods are less competitive.
- Provide clear preliminary data showing feasibility even at early stages. This reduces perceived risk.
- Align your team's expertise with the specific assay or therapeutic target. Show why your group is best positioned.
- Include a realistic timeline for achieving key milestones in the first funding period.
- Ensure institutional support is strong and committed to the translational focus of the work.
⚠️ Common mistakes
Not demonstrating sufficient innovation or explaining why existing assays/methods are inadequate. Proposing overly ambitious clinical validation instead of focusing on early-stage assay or target development. Providing weak or absent preliminary data supporting feasibility.
Similar grants
- OPEN 27-0343-10 FFY27 Local Agency General Non-Enforcement — Illinois Department of Transportation
- ROLLING Annual Agency Threshold Application Applicants for Funding Start Here — Texas City of Austin - Austin Public Health
- CLOSED Virginia’s Black Indigenous and People of Color (BIPOC) Grant – FY26 — Virginia The Virginia Department of Historic Resources
- ROLLING RTAP Grant Program (Rolling) — Virginia Department of Rail and Public Transportation
- ROLLING Rail Industrial Access Grant (RIA) — Virginia Department of Rail and Public Transportation